Gastroparesis Clinical Trial
Official title:
Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy
NCT number | NCT03259841 |
Other study ID # | 2017-8-4 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | October 31, 2017 |
Est. completion date | February 8, 2019 |
Verified date | May 2019 |
Source | SMG-SNU Boramae Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Investigators assess the gastric contents by ultrasonography in fasted patients undergoing cholecystectomy.
Status | Completed |
Enrollment | 140 |
Est. completion date | February 8, 2019 |
Est. primary completion date | February 8, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - Patients scheduled for cholecystectomy Exclusion Criteria: - Presence of gastric anatomic abnormality or pathology - A previous surgery of esophagus or stomach - Current pregnancy - Who could not lie in the right lateral decubitus (RLD) position |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Seoul Metropolitan Government Seoul National University Boramae Medical Center | Seoul |
Lead Sponsor | Collaborator |
---|---|
SMG-SNU Boramae Medical Center |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of full stomach | The incidence of full stomach is assessed by using ultrasonography. | Before the induction of anesthesia | |
Secondary | Cross sectional area of the stomach | The cross sectional area of the stomach is assessed by using ultrasonography in the supine and right lateral positions. | Before the induction of anesthesia | |
Secondary | Volume of stomach | The volume of stomach is assessed using the following formula; volume of stomach (mL) = 27.0 + 14.6 x cross-sectional area (right lateral position) - 1.28 x age. | Before the induction of anesthesia | |
Secondary | Type of gastric contents | The type of gastric contents is assessed using ultrasonography. | Before the induction of anesthesia |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03941288 -
Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia
|
Phase 2 | |
Terminated |
NCT03285308 -
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
|
Phase 3 | |
Completed |
NCT00733551 -
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
|
Phase 1 | |
Completed |
NCT01650714 -
Endoscopic Full Thickness Biopsy, Gastric Wall.
|
N/A | |
Completed |
NCT01452815 -
Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis
|
Phase 2 | |
Completed |
NCT01039974 -
GSK962040 Drug-drug Interaction Study With Ketoconazole
|
Phase 1 | |
Terminated |
NCT04844190 -
Use of EndoFLIP and Manometry Prior to G-POEM
|
N/A | |
Enrolling by invitation |
NCT06215547 -
Medtronic Enterra II Neurostimulator
|
N/A | |
Completed |
NCT04026997 -
A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis
|
Phase 2 | |
Completed |
NCT00562848 -
A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040
|
Phase 1 | |
Enrolling by invitation |
NCT04207996 -
Vagus Nerve Response in Gastroparesis Patients
|
||
Completed |
NCT04607304 -
ABCA2 GIRMS Analytical Validation Clinical Performance Study
|
N/A | |
Recruiting |
NCT06068114 -
Gastric Pathophysiology in Diabetes
|
||
Active, not recruiting |
NCT04300127 -
Pioglitazone for Idiopathic Gastroparesis
|
Early Phase 1 | |
Recruiting |
NCT01696734 -
Domperidone in Treating Patients With Gastrointestinal Disorders
|
Phase 3 | |
Terminated |
NCT04635306 -
13C-Spirulina Nitrogen Content GEBT Study
|
N/A | |
Withdrawn |
NCT02420925 -
Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis
|
N/A | |
Recruiting |
NCT00777439 -
Domperidone for Refractory Gastrointestinal Disorders
|
N/A | |
Terminated |
NCT00760461 -
Domperidone in Refractory Gastroparesis
|
Phase 2 | |
Completed |
NCT00612014 -
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis
|
Phase 2 |